Oncology Nursing Society

Chemotherapy

Supportive Care

Aromatherapy: Using Essential Oils as a Supportive Therapy

Debra Reis

Tisha Jones

CJON 2017, 21(1), 16-19 DOI: 10.1188/17.CJON.16-19

Essential oils can be a great adjunct to cancer care, aiding in the management of side effects, such as insomnia and nausea. Healthcare professionals should be knowledgeable about the quality and safety of essential oils when using them for clinical purposes. Using lesser quality essential oils and...

Average: 5 (2 votes)

Read this Article

Online Exclusive Article

Symptom Management: The Effects of Self-Affirmation on Chemotherapy-Related Symptoms

Meltem Yildirim

Hatice Gulsoy

Makbule Batmaz

Cansu Ozgat

Gulser Yesilbursali

Reyhan Aydin

Sedanur Ekiz

CJON 2017, 21(1), E15-E22 DOI: 10.1188/17.CJON.E15-E22

Background: Positive effects of auditory stimulations are common in symptom management. However, the effect of self-affirmations on symptom management is not well known. Objectives: The purpose of this study is to investigate the effects of self-affirmations and nature sounds on chemotherapy-...

No votes yet

Read this Article

Safety

U.S. Pharmacopeial Chapter <800>: Be Ready to Comply by July 2018

Martha Polovich

CJON 2017, 21(1), 116-119 DOI: 10.1188/17.CJON.116-119

The U.S. Pharmacopeial Convention’s “Chapter <800> Hazardous Drugs—Handling in Healthcare Settings” is a new part of the National Formulary that describes standards—expectations for practice—for all aspects of handling and administering hazardous drugs (HDs). Some of the standards will...

No votes yet

Read this Article

Article

Chemotherapy Safe Handling: Limiting Nursing Exposure With a Hazardous Drug Control Program

Rachael Crickman

CJON 2017, 21(1), 73-78 DOI: 10.1188/17.CJON.73-78

Background: Nurses and other healthcare workers are at risk for adverse health consequences from occupational exposure to hazardous drugs. Objectives: An evidence-based program for nurses was implemented to improve safe handling practices and reduce exposure to hazardous drugs. Methods: A...

Average: 4.7 (3 votes)

Read this Article

Essentials

On-Body Injector: An Administration Device for Pegfilgrastim

Linda J. Mahler

Regina DiBlasi

Anielka Perez

Jeannie Gaspard

Dayna McCauley

CJON 2017, 21(1), 121-122 DOI: 10.1188/17.CJON.121-122

Many chemotherapy regimens used today require the support of a granulocyte–colony-stimulating factor for the prevention of life-threatening neutropenia. In March 2015, a delivery method was introduced for Neulasta® (pegfilgrastim) through an on-body injector (Onpro®), which may eliminate the need...

No votes yet

Read this Article